Cargando…

Higher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases

Objective To evaluate the incremental increase in new onset diabetes from higher potency statins compared with lower potency statins when used for secondary prevention. Design Eight population based cohort studies and a meta-analysis. Setting Six Canadian provinces and two international databases fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dormuth, Colin R, Filion, Kristian B, Paterson, J Michael, James, Matthew T, Teare, Gary F, Raymond, Colette B, Rahme, Elham, Tamim, Hala, Lipscombe, Lorraine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038449/ https://www.ncbi.nlm.nih.gov/pubmed/24874977 http://dx.doi.org/10.1136/bmj.g3244

Ejemplares similares

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
por: Filion, Kristian B, et al.
Publicado: (2014)

Observational Studies of Drug Safety in Multi-Database Studies: Methodological Challenges and Opportunities
por: Platt, Robert W., et al.
Publicado: (2016)

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
por: Azoulay, Laurent, et al.
Publicado: (2016)

Comparative safety of direct oral anticoagulants and warfarin in venous thromboembolism: multicentre, population based, observational study
por: Jun, Min, et al.
Publicado: (2017)

Head to head comparison of the propensity score and the high-dimensional propensity score matching methods
por: Guertin, Jason R., et al.
Publicado: (2016)

Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort
por: Dormuth, Colin R., et al.
Publicado: (2021)

Patterns of antiemetic medication use during pregnancy: A multi-country retrospective cohort study
por: Fisher, Anat, et al.
Publicado: (2022)

Increased risk of diabetes with statin use: Reconsidering the use of high potency statins
por: Niazi, Asfandyar Khan
Publicado: (2014)

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
por: Filion, Kristian B, et al.
Publicado: (2020)

Rheumatism, and a Plea for Higher Potencies
por: Rushmore, Edward
Publicado: (1888)

A Few Cases Terminating Successfully under the Higher Potencies
por: Garrison, J. B.
Publicado: (1888)

Supplemental Plot of the Carcinogenic Potency Database
Publicado: (1999)

Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database.
por: Gold, L S, et al.
Publicado: (1989)

Frequency and predictors of tablet splitting in statin prescriptions: a population-based analysis
por: Dormuth, Colin R, et al.
Publicado: (2008)

Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
por: Chinwong, Dujrudee, et al.
Publicado: (2015)

The Incidence of Kidney Injury for Patients Treated With a High‐Potency Versus Moderate‐Potency Statin Regimen After an Acute Coronary Syndrome
por: Sarma, Amy, et al.
Publicado: (2014)

Higher dose statins after stroke
Publicado: (2021)

A carcinogenic potency database of the standardized results of animal bioassays
por: Gold, Lois Swirsky, et al.
Publicado: (1984)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Decreasing incidence of inflammatory bowel disease in Eastern Canada: a population database study
por: Leddin, Desmond, et al.
Publicado: (2014)

High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study
por: Lin, Tsung-Kun, et al.
Publicado: (2018)

Effect of high-potency statins on HbA1c in patients with or without diabetes mellitus
por: Ooba, Nobuhiro, et al.
Publicado: (2016)

For High Potencies
por: Fincke, B.
Publicado: (1897)

Higher Binding Affinity and In Vitro Potency of Reslizumab for Interleukin-5 Compared With Mepolizumab
por: Liddament, Mark, et al.
Publicado: (2018)

Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease
por: Renoux, Christel, et al.
Publicado: (2016)

High Potency Allœpathy
por: Gilbert, Charles B.
Publicado: (1890)

Increased Akt-Driven Glycolysis Is the Basis for the Higher Potency of CD137L-DCs
por: Zeng, Qun, et al.
Publicado: (2019)

CNODES: the Canadian Network for Observational Drug Effect Studies
por: Suissa, Samy, et al.
Publicado: (2012)

Statin Use is Associated With Insulin Resistance in Participants of the Canadian Multicentre Osteoporosis Study
por: Rees-Milton, Karen J, et al.
Publicado: (2020)

Clinical Confirmation of High Potencies
por: Baylies, B. L. B.
Publicado: (1888)

Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982.
por: Gold, L S, et al.
Publicado: (1986)

Statin use and cancer risk in the General Practice Research Database
por: Kaye, J A, et al.
Publicado: (2004)

The Centesimality of the Fincke High Potencies
por: Fincke, B.
Publicado: (1882)

Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
por: Hartz, Ingeborg, et al.
Publicado: (2007)

Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits
por: Morrow, Richard L, et al.
Publicado: (2019)

Factors related to the frequency of citation of epidemiologic publications
por: Filion, Kristian B, et al.
Publicado: (2008)

Fluxion Potencies
por: Skinner, Thos.
Publicado: (1882)

The Potency Question
Publicado: (1894)

Sixth plot of the carcinogenic potency database: results of animal bioassays published in the General Literature 1989 to 1990 and by the National Toxicology Program 1990 to 1993.
por: Gold, L S, et al.
Publicado: (1995)

Gestational diabetes and risk of cardiovascular disease: a scoping review
por: Archambault, Cyril, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cdt3lv41uejovhdkg1k8pv58cs